Regulus Therapeutics Inc.
NASDAQ:RGLS
1.49 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -30.037 | -28.323 | -27.808 | -15.73 | -18.592 | -48.709 | -71.905 | -81.836 | -55.748 | -56.68 | -18.668 | -17.408 | -7.602 | -15.559 |
| Depreciation & Amortization
| 0.227 | 0.122 | 0.459 | 0.467 | 0.931 | 2.262 | 2.524 | 2.276 | 1.591 | 1.49 | 1.36 | 1.017 | 0.911 | 0.494 |
| Deferred Income Tax
| -0.029 | 0 | -0.662 | 0 | 0 | 0.148 | 0.349 | 0.666 | -15.27 | 5.097 | -2.302 | 3.165 | 8.152 | 0.394 |
| Stock Based Compensation
| 2.801 | 2.177 | 2.923 | 2.614 | 2.288 | 5.441 | 7.642 | 12.872 | 15.368 | 7.039 | 3.422 | 1.55 | 0.825 | 0.603 |
| Change In Working Capital
| 0.257 | 0.55 | 0.914 | -0.041 | -6.58 | -3.171 | 2.017 | 8.097 | -14.451 | -5.092 | -17.028 | 0.983 | -9.747 | 25.857 |
| Accounts Receivables
| 0 | 0 | 0.503 | 0.638 | -1.115 | 0.347 | 1.284 | 6.641 | -9.746 | -0.196 | -0.079 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0.001 | 0 | -0.606 | 0.394 | -0.616 | -3.46 | -0.641 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.029 | -0.11 | -0.25 | -0.786 | -0.393 | -4.029 | -0.065 | 3.123 | 0.529 | 0.94 | 0.86 | -0.189 | -0.793 | 0.574 |
| Other Working Capital
| 0.228 | 0.66 | 0.661 | 0.106 | -5.072 | 1.117 | 2.082 | -1.051 | -14.98 | -6.032 | -17.888 | 1.172 | -8.954 | 25.283 |
| Other Non Cash Items
| 0.013 | -0.052 | 0.046 | 0.154 | 2.132 | 0.756 | 0.6 | 1.043 | 18.651 | 8.636 | 4.886 | 1.972 | -7.602 | 0.518 |
| Operating Cash Flow
| -26.768 | -25.526 | -24.128 | -12.536 | -19.821 | -43.273 | -58.773 | -56.882 | -49.859 | -39.51 | -28.33 | -8.721 | -15.063 | 12.307 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -0.613 | -0.361 | -0.251 | -0.011 | -0.244 | -0.022 | -0.319 | -0.966 | -1.43 | -1.211 | -0.835 | -1.426 | -0.598 | -2.415 |
| Acquisitions Net
| 0.003 | 0.015 | 0 | 0 | 0.318 | 0 | 0.016 | 0.053 | 0.067 | 0.065 | 0.035 | 0.275 | 0.131 | 0.531 |
| Purchases Of Investments
| -4.899 | -32.759 | 0 | 0 | 0 | 0 | -55.686 | -65.11 | -78.401 | -113.417 | -72.005 | -62.041 | -50.663 | -43.477 |
| Sales Maturities Of Investments
| 20 | 18 | 0 | 0 | 0 | 46.541 | 69.941 | 101.387 | 101.306 | 85.421 | 31.951 | 33.083 | 54.585 | 23.932 |
| Other Investing Activites
| 0.015 | -0.015 | 0 | -0 | 0 | 46.541 | -0.016 | -0.053 | -0.067 | -0.065 | -0.035 | -0.275 | -0.131 | -0.531 |
| Investing Cash Flow
| 14.491 | -15.12 | -0.251 | -0.011 | 0.074 | 46.519 | 13.936 | 35.311 | 21.475 | -29.207 | -40.889 | -30.384 | 3.324 | -21.96 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| -3.304 | 0 | -0.08 | -10.277 | -2.24 | -3.342 | 0 | -0.167 | -0.155 | 0 | 0 | -0.445 | -0.412 | -0.353 |
| Common Stock Issued
| 15.12 | 4.491 | 53.791 | 19.123 | 42.17 | 0.219 | 43.411 | 0.641 | 7.172 | 88.379 | 46.574 | 65.927 | 0.058 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.699 | 0.004 | 0.026 | 0.667 | 0.003 | 0.293 | 0.004 | 20.078 | -0.155 | -0.142 | -0.1 | 5 | 0 | 15.046 |
| Financing Cash Flow
| 11.816 | 4.491 | 53.737 | 9.513 | 39.933 | -2.83 | 43.415 | 20.552 | 7.017 | 88.237 | 46.474 | 70.482 | -0.354 | 14.693 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.461 | -36.155 | 29.358 | -3.034 | 20.186 | 0.416 | -1.422 | -1.019 | -21.367 | 19.52 | -22.745 | 31.377 | -12.093 | 5.04 |
| Cash At End Of Period
| 23.829 | 24.29 | 60.445 | 31.087 | 34.121 | 13.935 | 13.519 | 14.941 | 15.96 | 37.327 | 17.807 | 40.552 | 9.175 | 21.268 |